Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Viral hepatitis.

McQuillian GM, Kruszon-Moran D, Denniston MM, Hirsch R.

NCHS Data Brief. 2010 Mar;(27):1-8.

2.

Surveillance for acute viral hepatitis - United States, 2007.

Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2009 May 22;58(3):1-27.

3.

Surveillance for acute viral hepatitis--United States, 2006.

Wasley A, Grytdal S, Gallagher K; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2008 Mar 21;57(2):1-24.

4.

Prevalence of hepatitis A, B, C, and E antibody in flying airline personnel.

Andenaes S, Lie A, Degré M.

Aviat Space Environ Med. 2000 Dec;71(12):1178-80.

PMID:
11439715
5.

Viral hepatitis in Bucharest.

Paquet C, Babes VT, Drucker J, Sénémaud B, Dobrescu A.

Bull World Health Organ. 1993;71(6):781-6.

6.

The prevalence of hepatitis B virus infection in the United States in the era of vaccination.

Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, Bell B.

J Infect Dis. 2010 Jul 15;202(2):192-201. doi: 10.1086/653622.

PMID:
20533878
7.

Antibodies against hepatitis viruses in merchant seamen.

Hansen HL, Andersen PL, Brandt L, Broløs O.

Scand J Infect Dis. 1995;27(3):191-4.

PMID:
8539539
8.
9.

[Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].

Michault A, Faulques B, Sevadjan B, Troalen D, Marais A, Barau G.

Bull Soc Pathol Exot. 2000 Feb;93(1):34-40. French.

PMID:
10774493
10.

High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia.

Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, Hasegawa K, Altankhuu M, Chimedregzen U, Narantuya L, Hoshino H, Hino K, Kagawa Y, Okamoto H.

Clin Diagn Lab Immunol. 2004 Mar;11(2):392-8.

11.

Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.

Hartleb M, Gutkowski K, Zejda JE, Chudek J, Więcek A.

Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1288-95.

PMID:
22864260
12.

[Prevalence of anti-HAV antibodies in Warsaw population].

Janaszek-Seydlitz W, Bucholc B, Wiatrzyk A.

Przegl Epidemiol. 2007;61(4):675-82. Polish.

PMID:
18572499
13.

[Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].

Chlíbek R, Cecetková B, Smetana J, Prymula R, Kohl I.

Epidemiol Mikrobiol Imunol. 2006 Aug;55(3):99-104. Czech.

PMID:
16970073
14.

Surveillance for acute viral hepatitis--United States, 2005.

Wasley A, Miller JT, Finelli L; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2007 Mar 16;56(3):1-24.

15.

Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia.

Ohba K, Mizokami M, Kato T, Ueda R, Gurtsenvitch V, Senyuta N, Syrtsev A, Zoya K, Yamashita M, Hayami M.

Epidemiol Infect. 1999 Feb;122(1):139-43.

18.

Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.

Gutiérrez Domingo I, Pascasio Acevedo JM, Alcalde Vargas A, Ramos Cuadra A, Ferrer Ríos MT, Sousa Martín JM, Sayago Mota M, Giráldez Gallego A, Suárez Artacho G.

Transplant Proc. 2012 Jul-Aug;44(6):1502-4. doi: 10.1016/j.transproceed.2012.05.020.

PMID:
22841196
19.

Hepatitis B and C in New South Wales prisons: prevalence and risk factors.

Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW.

Med J Aust. 1997 Feb 3;166(3):127-30.

PMID:
9059433
20.

Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.

Collier MG, Drobeniuc J, Cuevas-Mota J, Garfein RS, Kamili S, Teshale EH.

Vaccine. 2015 Jun 4;33(24):2808-12. doi: 10.1016/j.vaccine.2015.04.019. Epub 2015 Apr 15.

PMID:
25889161

Supplemental Content

Support Center